By Afsaneh Gray, medwireNews Reporter A study of first-episode psychosis patients in Hong Kong has found that those with fewer negative symptoms at presentation and poor medication compliance were more likely than others to disengage from ...
Tags: Intervention, Disengagement, negative symptom, schizoaffective disorder
By Afsaneh Gray, medwireNews Reporter A study of first-episode psychosis patients in Hong Kong has found that those with fewer negative symptoms at presentation and poor medication compliance were more likely than others to disengage from ...
Tags: Intervention, Disengagement, negative symptom, schizoaffective disorder
For people with serious mental illness who are trying to quit smoking, extending their treatment with the smoking cessation drug Chantix (varenicline) may help them avoid a relapse, according to a new study. After a standard 12-week ...
Tags: mental illness, quit smoking, Chantix, avoid relapse
By Joanna Lyford, Senior medwireNews Reporter Diminished expression (DE), a core negative symptom in people with schizophrenia, is significantly correlated with an array of cognitive functions, research by a Hong Kong team shows. ...
Tags: diminished expression, negative symptom, schizophrenia
In the largest ever assessment of substance use among people with severe psychiatric illness, researchers at Washington University School of Medicine in St. Louis and the University of Southern California have found that rates of smoking, ...
Tags: psychiatric illness, psychotic disorders, rates of smoking
Zogenix has commenced first IND clinical trial for Relday in patients with chronic, stable schizophrenia or schizoaffective disorder. Relday is based on a combination of its DosePro needle-free, subcutaneous drug delivery system with a ...
Tags: Clinical Trial, DosePro needle-free drug, pharmacokinetic